(BOOM) Dmc Global - Overview
Sector: IndustrialsIndustry: Conglomerates | Exchange NASDAQ (USA) | Currency USD | Market Cap: 100m | Total Return -45.4% in 12m
Stock: Aluminum Framing, Perforating Systems, Clad Metal
Total Rating 24
Risk 70
Buy Signal -1.49
| Risk 5d forecast | |
|---|---|
| Volatility | 58.5% |
| Relative Tail Risk | -11.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.54 |
| Alpha | -66.23 |
| Character TTM | |
|---|---|
| Beta | 1.375 |
| Beta Downside | 1.972 |
| Drawdowns 3y | |
|---|---|
| Max DD | 82.30% |
| CAGR/Max DD | -0.47 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
choppy
Description: BOOM Dmc Global March 04, 2026
DMC Global Inc. (BOOM) provides engineered products across three segments: construction, energy, and industrial processing. The company operates in sectors sensitive to commodity prices and infrastructure spending.
The Arcadia Products segment manufactures architectural aluminum systems for commercial and residential buildings. This includes curtain walls and entrance systems, common in commercial real estate development.
DynaEnergetics supplies perforating systems and hardware for the oil and gas industry. This segments performance is closely tied to upstream oil and gas activity.
NobelClad produces explosion-welded clad metal plates used in heavy industrial applications, such as pressure vessels for chemical processing and power generation. This technology provides corrosion resistance in demanding environments.
Further research on ValueRay can provide deeper insights into BOOMs financial performance and market position.
Headlines to watch out for
- Oil and gas industry capital expenditures drive DynaEnergetics segment revenue
- Commercial construction activity impacts Arcadia Products segment sales
- Raw material cost fluctuations affect all segment profitability
- Global industrial project spending influences NobelClad demand
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -17.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 1.56 > 1.0 |
| NWC/Revenue: 28.21% < 20% (prev 27.21%; Δ 1.00% < -1%) |
| CFO/TA 0.09 > 3% & CFO 54.2m > Net Income -17.9m |
| Net Debt (18.7m) to EBITDA (32.8m): 0.57 < 3 |
| Current Ratio: 2.50 > 1.5 & < 3 |
| Outstanding Shares: last quarter (19.9m) vs 12m ago 0.92% < -2% |
| Gross Margin: 19.05% > 18% (prev 0.23%; Δ 1.88k% > 0.5%) |
| Asset Turnover: 93.31% > 50% (prev 95.76%; Δ -2.45% > 0%) |
| Interest Coverage Ratio: -0.18 > 6 (EBITDA TTM 32.8m / Interest Expense TTM 6.49m) |
Altman Z'' 1.51
| A: 0.27 (Total Current Assets 286.4m - Total Current Liabilities 114.3m) / Total Assets 635.8m |
| B: -0.02 (Retained Earnings -13.5m / Total Assets 635.8m) |
| C: -0.00 (EBIT TTM -1.19m / Avg Total Assets 653.6m) |
| D: -0.18 (Book Value of Equity -37.1m / Total Liabilities 206.7m) |
| Altman-Z'' Score: 1.51 = BB |
Beneish M -3.05
| DSRI: 0.96 (Receivables 93.7m/103.4m, Revenue 609.8m/642.9m) |
| GMI: 1.23 (GM 19.05% / 23.42%) |
| AQI: 0.93 (AQ_t 0.35 / AQ_t-1 0.38) |
| SGI: 0.95 (Revenue 609.8m / 642.9m) |
| TATA: -0.11 (NI -17.9m - CFO 54.2m) / TA 635.8m) |
| Beneish M-Score: -3.05 (Cap -4..+1) = AA |
What is the price of BOOM shares?
As of March 25, 2026, the stock is trading at USD 4.89 with a total of 188,938 shares traded.
Over the past week, the price has changed by -2.98%, over one month by -16.27%, over three months by -25.80% and over the past year by -45.36%.
Over the past week, the price has changed by -2.98%, over one month by -16.27%, over three months by -25.80% and over the past year by -45.36%.
Is BOOM a buy, sell or hold?
Dmc Global has received a consensus analysts rating of 3.33.
Therefor, it is recommend to hold BOOM.
- StrongBuy: 0
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BOOM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 8.5 | 73.8% |
| Analysts Target Price | 8.5 | 73.8% |
BOOM Fundamental Data Overview March 24, 2026
P/E Forward = 42.3729
P/S = 0.1641
P/B = 0.4024
P/EG = 0.4931
Revenue TTM = 609.8m USD
EBIT TTM = -1.19m USD
EBITDA TTM = 32.8m USD
Long Term Debt = 47.2m USD (from longTermDebt, last quarter)
Short Term Debt = 3.44m USD (from shortTermDebt, last quarter)
Debt = 50.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 18.7m USD (from netDebt column, last quarter)
Enterprise Value = 118.8m USD (100.1m + Debt 50.6m - CCE 31.9m)
Interest Coverage Ratio = -0.18 (Ebit TTM -1.19m / Interest Expense TTM 6.49m)
EV/FCF = 3.15x (Enterprise Value 118.8m / FCF TTM 37.7m)
FCF Yield = 31.71% (FCF TTM 37.7m / Enterprise Value 118.8m)
FCF Margin = 6.18% (FCF TTM 37.7m / Revenue TTM 609.8m)
Net Margin = -2.93% (Net Income TTM -17.9m / Revenue TTM 609.8m)
Gross Margin = 19.05% ((Revenue TTM 609.8m - Cost of Revenue TTM 493.6m) / Revenue TTM)
Gross Margin QoQ = 7.11% (prev 18.52%)
Tobins Q-Ratio = 0.19 (Enterprise Value 118.8m / Total Assets 635.8m)
Interest Expense / Debt = 2.67% (Interest Expense 1.35m / Debt 50.6m)
Taxrate = 21.0% (US default 21%)
NOPAT = -937k (EBIT -1.19m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.50 (Total Current Assets 286.4m / Total Current Liabilities 114.3m)
Debt / Equity = 0.21 (Debt 50.6m / totalStockholderEquity, last quarter 242.1m)
Debt / EBITDA = 0.57 (Net Debt 18.7m / EBITDA 32.8m)
Debt / FCF = 0.50 (Net Debt 18.7m / FCF TTM 37.7m)
Total Stockholder Equity = 250.7m (last 4 quarters mean from totalStockholderEquity)
RoA = -2.74% (Net Income -17.9m / Total Assets 635.8m)
RoE = -7.14% (Net Income TTM -17.9m / Total Stockholder Equity 250.7m)
RoCE = -0.40% (EBIT -1.19m / Capital Employed (Equity 250.7m + L.T.Debt 47.2m))
RoIC = -0.30% (negative operating profit) (NOPAT -937k / Invested Capital 308.0m)
WACC = 7.89% (E(100.1m)/V(150.7m) * Re(10.82%) + D(50.6m)/V(150.7m) * Rd(2.67%) * (1-Tc(0.21)))
Discount Rate = 10.82% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.80%
[DCF] Terminal Value 74.64% ; FCFF base≈34.3m ; Y1≈26.6m ; Y5≈17.0m
[DCF] Fair Price = 15.05 (EV 327.2m - Net Debt 18.7m = Equity 308.4m / Shares 20.5m; r=7.89% [WACC]; 5y FCF grow -26.78% → 3.0% )
EPS Correlation: -40.04 | EPS CAGR: -18.28% | SUE: -1.86 | # QB: 0
Revenue Correlation: -41.40 | Revenue CAGR: 0.91% | SUE: 0.15 | # QB: 0
EPS next Quarter (2026-06-30): EPS=-0.20 | Chg7d=-0.200 | Chg30d=-0.200 | Revisions Net=+1 | Analysts=2
EPS current Year (2026-12-31): EPS=-0.52 | Chg7d=-0.550 | Chg30d=-0.630 | Revisions Net=-1 | Growth EPS=-48.6% | Growth Revenue=-2.7%
EPS next Year (2027-12-31): EPS=0.37 | Chg7d=+0.370 | Chg30d=+0.370 | Revisions Net=+0 | Growth EPS=+171.2% | Growth Revenue=+7.6%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
P/S = 0.1641
P/B = 0.4024
P/EG = 0.4931
Revenue TTM = 609.8m USD
EBIT TTM = -1.19m USD
EBITDA TTM = 32.8m USD
Long Term Debt = 47.2m USD (from longTermDebt, last quarter)
Short Term Debt = 3.44m USD (from shortTermDebt, last quarter)
Debt = 50.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 18.7m USD (from netDebt column, last quarter)
Enterprise Value = 118.8m USD (100.1m + Debt 50.6m - CCE 31.9m)
Interest Coverage Ratio = -0.18 (Ebit TTM -1.19m / Interest Expense TTM 6.49m)
EV/FCF = 3.15x (Enterprise Value 118.8m / FCF TTM 37.7m)
FCF Yield = 31.71% (FCF TTM 37.7m / Enterprise Value 118.8m)
FCF Margin = 6.18% (FCF TTM 37.7m / Revenue TTM 609.8m)
Net Margin = -2.93% (Net Income TTM -17.9m / Revenue TTM 609.8m)
Gross Margin = 19.05% ((Revenue TTM 609.8m - Cost of Revenue TTM 493.6m) / Revenue TTM)
Gross Margin QoQ = 7.11% (prev 18.52%)
Tobins Q-Ratio = 0.19 (Enterprise Value 118.8m / Total Assets 635.8m)
Interest Expense / Debt = 2.67% (Interest Expense 1.35m / Debt 50.6m)
Taxrate = 21.0% (US default 21%)
NOPAT = -937k (EBIT -1.19m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.50 (Total Current Assets 286.4m / Total Current Liabilities 114.3m)
Debt / Equity = 0.21 (Debt 50.6m / totalStockholderEquity, last quarter 242.1m)
Debt / EBITDA = 0.57 (Net Debt 18.7m / EBITDA 32.8m)
Debt / FCF = 0.50 (Net Debt 18.7m / FCF TTM 37.7m)
Total Stockholder Equity = 250.7m (last 4 quarters mean from totalStockholderEquity)
RoA = -2.74% (Net Income -17.9m / Total Assets 635.8m)
RoE = -7.14% (Net Income TTM -17.9m / Total Stockholder Equity 250.7m)
RoCE = -0.40% (EBIT -1.19m / Capital Employed (Equity 250.7m + L.T.Debt 47.2m))
RoIC = -0.30% (negative operating profit) (NOPAT -937k / Invested Capital 308.0m)
WACC = 7.89% (E(100.1m)/V(150.7m) * Re(10.82%) + D(50.6m)/V(150.7m) * Rd(2.67%) * (1-Tc(0.21)))
Discount Rate = 10.82% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.80%
[DCF] Terminal Value 74.64% ; FCFF base≈34.3m ; Y1≈26.6m ; Y5≈17.0m
[DCF] Fair Price = 15.05 (EV 327.2m - Net Debt 18.7m = Equity 308.4m / Shares 20.5m; r=7.89% [WACC]; 5y FCF grow -26.78% → 3.0% )
EPS Correlation: -40.04 | EPS CAGR: -18.28% | SUE: -1.86 | # QB: 0
Revenue Correlation: -41.40 | Revenue CAGR: 0.91% | SUE: 0.15 | # QB: 0
EPS next Quarter (2026-06-30): EPS=-0.20 | Chg7d=-0.200 | Chg30d=-0.200 | Revisions Net=+1 | Analysts=2
EPS current Year (2026-12-31): EPS=-0.52 | Chg7d=-0.550 | Chg30d=-0.630 | Revisions Net=-1 | Growth EPS=-48.6% | Growth Revenue=-2.7%
EPS next Year (2027-12-31): EPS=0.37 | Chg7d=+0.370 | Chg30d=+0.370 | Revisions Net=+0 | Growth EPS=+171.2% | Growth Revenue=+7.6%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)